Skip to main content
. 2014 Jul 12;71(22):4325–4346. doi: 10.1007/s00018-014-1677-1

Table 9.

Rapamycin and gene expression studies using microarrays in mice

Strain, sex Intervention Organ Genes up-regulated Genes down-regulated Pathways involved Reference
Male and female C57BL/6J Oral rapamycin (encapsulated, 14 ppm) initiated at 4 months of age for 21 months Liver 159 (males), 2,504 (females) 129 (males), 2,257 (females) 13 [77]
Oral rapamycin (encapsulated, 14 ppm) initiated at 19 months of age for 6 months 32 (males), 675 (females) 68 (males), 752 (females) 3
Male C57BL/6 Oral rapamycin (encapsulated, 14 ppm) initiated at 2 months of age with duration of 6 months Liver 783 628 105 [78]
40 % dietary restriction initiated at 2 months of age with duration of 6 months 1,621 256 88
40 % dietary restriction combined with oral rapamycin treatment (encapsulated, 14 ppm) initiated at 2 months of age with duration of 6 months 2,558 1,130 170